FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors


+0 (0%)
Updated 05:30 01/01 IST

WANBURY Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for WANBURY
0% Bullish
0% Bearish

WANBURY Buy or Sell - Brokerage Reports

No. of reports in last year
No. of analysts
Average Consensus Forecast
Consensus Potential
See WANBURY Share Price Targets >>


Long term WANBURY rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live WANBURY message board: Is WANBURY buy or sell? Should I buy WANBURY shares? Why are WANBURY shares falling? Should I invest in WANBURY stock?

  1. Home
  2. WANBURY Forum

WANBURY Share Price Discussion

No posts yet.
This service may be new or inactive. Please check back later.
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • WANBURY - Share Price - Fundamentals

    Market Capitalization73.53
    Enterprise Value291.35
    Price to Earnings38.85
    Price to Book Value0.53
    Return on Capital Employed-0.02
    Return on Equity0.2
    Face Value10
    Dividend YieldNA
  • WANBURY - Profit And Loss

    CONSOLIDATEDMar-18Mar-17 % Change
    Operating Profit-6718.86-4.55
    Profit Before Tax-32-4.615.94
    Net Income-32-5.055.34
  • WANBURY - Balance Sheet

    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds-159-189.58-0.16
    Total Liabilities430606.32-0.29
    Total Assets270416.74-0.35
  • WANBURY - Cash Flow

    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity3243.39-0.26
    Cash from Investing Activity-1-13.53-0.93
    Cash from Financing Activity-33-26.470.25
    Net Cash Flow-23.4-1.59
  • WANBURY - Ratios

    Return on Assets-0.12-0.01
    Return on Equity0.20.03
    Return on Capital Employed-0.020.09
  • WANBURY - 3 year Growth

    3 Year CAGR Growth in Revenue0.49
    3 Year CAGR Growth in Operating Profit-4.13
    3 Year CAGR Growth in EBIDTA1.14
    3 Year CAGR Growth in Net Income-10.97
    3 Yr CAGR Growth - Diluted EPS-9.38
  • WANBURY - 5 year Growth

    5 Year CAGR Growth in Revenue-0.1
    5 Year CAGR Growth in Operating Profit-5.2
    5 Year CAGR Growth in EBIDTA0.02
    5 Year CAGR Growth in Net Income-0.26
    3 Yr CAGR Growth - Diluted EPS0.08
  • WANBURY - Related Communities

    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

FrontPage © 2020